Albany Molecular Research, Inc. (NASDAQ:AMRI)
CAPS Rating:
The Company is a global chemistry-based drug discovery and development company focused on identifying and developing novel biologically active small molecules with applications in the drug market.
RSS Headlines
Fool UK
Recs
BUYING AT 5 PER SHARE, stock is valued in my fair value estimates at 5.40 a share i expect movement at this price in late summer.
good company worth 5 or more a share.